ROYAL BANK OF CANADA - AYTU BIOPHARMA INC ownership

AYTU BIOPHARMA INC's ticker is AYTU and the CUSIP is 054754874. A total of 55 filers reported holding AYTU BIOPHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of AYTU BIOPHARMA INC
ValueSharesWeighting
Q4 2022$0511
+6.7%
0.00%
Q3 2022$0479
+0.6%
0.00%
Q2 2022$0
-100.0%
4760.0%0.00%
Q1 2022$1,0000.0%476
-6.3%
0.00%
Q4 2021$1,0000.0%508
-13.0%
0.00%
Q3 2021$1,000
-96.6%
584
-89.9%
0.00%
Q2 2021$29,000
+93.3%
5,764
+189.6%
0.00%
Q1 2021$15,000
+1400.0%
1,990
+1050.3%
0.00%
Q4 2020$1,0001730.00%
Other shareholders
AYTU BIOPHARMA INC shareholders Q3 2022
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 1,262,516$234,0000.30%
Ayrton Capital LLC 452,221$84,0000.15%
Allred Capital Management, LLC 105,000$19,0000.01%
Alyeska Investment Group, L.P. 1,500,000$278,0000.00%
CVI Holdings, LLC 141,877$26,0000.00%
Walleye Capital LLC 582,500$108,0000.00%
Warberg Asset Management LLC 65,002$12,0000.00%
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC 10,880$2,0000.00%
Affinity Capital Advisors, LLC 11,415$2,0000.00%
Focused Wealth Management, Inc 1,209$00.00%
View complete list of AYTU BIOPHARMA INC shareholders